Germany's BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of a new c...

January 16, 2025 | Thursday | News
HKUST signs MoU with Microsoft Research Asia fostering collaboration in future medical education and research

The Hong Kong University of Science and Technology (HKUST) has signed a Memorandum of Understanding (MoU) with Microsoft...

January 15, 2025 | Wednesday | News
Health Research Council in New Zealand puts $4.3 M into University projects

More than $4.3 million from the Health Research Council in New Zealand will allow University of Auckland researchers to ...

January 13, 2025 | Monday | News
Australia's Telix Pharma buys next-gen therapeutic assets from ImaginAb

Australia-based Telix Pharmaceuticals has entered into an asset purchase agreement with US-based antibody engineering co...

January 13, 2025 | Monday | News
Singapore launches industry-ready skill programs through interdisciplinary collaboration between academia, biopharma and the EDB

RP launched the Talent Advancement Programme (TAP), a first-of-its-kind initiative across local polytechnics...

January 9, 2025 | Thursday | News
AusBiotech and BioNSW sign MoU to deepen collaboration in life sciences sector

AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, has for...

January 9, 2025 | Thursday | News
Taiwan-based startup Primo Biotech partners with SHINE Technologies to advance precision cancer care in APAC

Taiwan-based startup Primo Biotechnology has announced a strategic partnership with US-based SHINE Technologies, LLC, a ...

January 9, 2025 | Thursday | News
SunAct & CytoMed join hands for Ph 2 clinical trials of innovative cancer therapy in India

India's SunAct Cancer Institute has announced the start of Phase 2 clinical trials on a groundbreaking treatme...

January 7, 2025 | Tuesday | News
Japan's Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson & Johnson for $1.2 B

Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...

January 7, 2025 | Tuesday | News
China's Innovent Biologics enters into billion dollar oncology deal with Roche

China-based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercial...

January 4, 2025 | Saturday | News
Entrepreneur of the year 2024-Dr Lynne Lim (NousQ)

Practicing as an Ear Nose Throat (ENT) surgeon for 25 years, and having received opportunities to help with surgeries in...

January 2, 2025 | Thursday | Analysis
Startup of the year 2024- ImmunoACT

Spun-out from the Indian Institute of Technology Bombay (IIT-B) in 2018, ImmunoACT is India's pioneer in the development...

January 2, 2025 | Thursday | Analysis
Needle free injection system technology by IntegriMedical- Building the Future of Medicine

Founded in 2020, IntegriMedical embarked on a mission to revolutionise healthcare by tackling one of the most persistent...

January 2, 2025 | Thursday | Analysis
“There lies a more sustainable future in biomanufacturing as we head into 2025 and beyond”

Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian co...

January 2, 2025 | Thursday | Analysis
Radiopharm announces strategic co-development partnership with Lantheus for Australia

Radiopharm Theranostics, a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharm...

January 4, 2025 | Saturday | News
Partnership in China to build new ecosystem for antibody-drug conjugates

Porton Pharma Solutions and Dragon Sail Pharmaceutical (Shanghai) have signed a strategic cooperation agreement in Guili...

December 24, 2024 | Tuesday | News
USFDA gives Orphan Drug Designation and Rare Paediatric Disease Designation to Aptamer developed in Hong Kong

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to S...

December 23, 2024 | Monday | News
Merck strikes partnership worth $1.9 B with Chinese biotech Hansoh for treatment of cardiometabolic diseases

Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, hav...

December 23, 2024 | Monday | News